Provided by Tiger Trade Technology Pte. Ltd.

Renaissance Technologies Holdings

3,084.25
+33.341.09%
Number of Gainers:57
Number of Losers:35
Number of Flat:4
PE:- -
High:3,099.45
Open:3,053.63
Low:3,053.63
Close:3,050.91
Volume:699.53M
Turnover:160.98B
Market Cap:33.63T
Float Cap:31.70T

Loading ...

Micron Stock (MU) Is Volatile Ahead of Q4 Earnings on Sept. 30. Here’s Why

TIPRANKS
·
Sep 25

Target Declares R$ 3.95054379 Dividend Per Unit for 2026 Fourth Quarter

Reuters
·
Sep 25

Northrop Grumman awarded $123.8M U.S. Navy contract

TIPRANKS
·
Sep 25

Snowflake Director Benoit Dageville Disposes of Common Shares Worth $16.95 Million

Reuters
·
Sep 25

Kinross trims 2026–27 output guidance but boosts 2026 capital returns

TIPRANKS
·
Sep 25

Google Reaches 5-Year Deal with BNP Paribas to Expand Access to Gemini Models

TIPRANKS
·
Sep 25

Microsoft President Brad Smith to Lead Communications Department

Reuters
·
Sep 25

General Mills Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Otis Worldwide Corp. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Sep 25

Kroger Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 25

Videogame Stocks Fall After Meta Announces AI Game Tool. Don't be Spooked Yet.

Dow Jones
·
Sep 25

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Reuters
·
Sep 25

Newmont Schedules Third-Quarter 2026 Results Conference Call

Reuters
·
Sep 25

Monster Beverage Corp. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Lowe's Cos. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Qualcomm Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Dow Jones
·
Sep 25

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

TIPRANKS
·
Sep 25

United Therapeutics Chairperson, CEO Martine A. Rothblatt Reports Disposal of Common Shares Worth $4.4 Million

Reuters
·
Sep 25